Page 25 - அறிக்கை தொடர்பாக முன்னோக்கி பார்க்கிறது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities

Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities Sanofi will invest €400 million over five years to create a unique vaccine

United statesFrance generalEva schaefer jansenArnaud delepineNicolas kressmannSuzanne grecoFelix lauscherFara berkowitzSanofi pasteurThomas triompheSingapore economic development boardNorth americaExecutive vice presidentGlobal headPrivate securities litigation reform actStatement regarding forward looking

Signature Aviation U S Holdings, Inc announces a consent solicitation for its 4 000% Senior Notes due 2028

Press release content from PR Newswire. The AP news staff was not involved in its creation. Signature Aviation U.S. Holdings, Inc. announces a consent solicitation for its 4.000% Senior Notes due 2028 April 9, 2021 GMT NEW YORK, April 8, 2021 /PRNewswire/ Signature Aviation US Holdings, Inc. (the “Issuer”), a Delaware corporation and wholly-owned subsidiary of Signature Aviation plc (“Signature”), announces that it has commenced a solicitation of consents (the “Consent Solicitation”) from holders (the “Holders”) of its 4.000% Senior Notes due 2028 (the “Notes”) to certain proposed amendments to the Indenture dated as of November 1, 2019 under which the Notes were issued (the “Indenture”) among the Issuer, Signature, BBA US Investments S.À R.L and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). The Issuer continues to evaluate alternatives in respect of its outstanding 5.375% notes due May 1, 2026, including potential call

New yorkUnited statesCity ofUnited kingdomLondon stock exchangeCapital marketsBank financingMelinda gates foundationBank financing for the acquisitionPrnewswire signature aviation us holdings incBrown bidco limitedYork mellon trust companyBlackstone core equity management associatesBrown group holdingGlobal infrastructure managementUk companies

Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofi s novel investigational IL-2

Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofi s novel investigational IL-2 Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofi s novel investigational IL-2 Early clinical results are consistent with preclinical studies and suggest THOR-707 (SAR444245) may promote an anti-tumor immune response without alpha-mediated side effects, both alone and in combination with anti-PD-1 THOR-707, a precisely PEGylated, engineered version of IL-2 built on Sanofi s Synthorin technology platform, is being studied in a trial of adults with advanced or metastatic solid tumors PARIS - April 9, 2021 - Interim data from a first-in-human trial evaluating the safety, therapeutic activity and maximum tolerable dose of THOR-707 (SAR444245), a highly differentiated not-alpha interleukin-2 (IL-2) candidate, as a monotherapy and in combination with anti-PD-1, will be presented Saturday, April 10 as a late-breaking po

United statesFrance generalEva schaefer jansenArnaud delepineSuzanne grecoFelix lauscherSanofi synthorinJohn reedFilip jankuFara berkowitzSally bainDivision of cancer medicineGlobal head of research developmentAmerican association for cancer researchUniversity of texas md anderson cancer centerMerck co

Johnson Controls Agrees to Acquire Silent-Aire to Accelerate Growth in Hyperscale Data Center Vertical

Share this article Share this article CORK, Ireland, April 9, 2021 /PRNewswire/ Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, today announced it has entered into a definitive agreement to acquire Silent-Aire, a global leader in hyperscale data center cooling and modular critical infrastructure solutions. This all-cash transaction is valued at up to $870 million, including an upfront payment of approximately $630 million and additional payments to be made subject to the achievement of post-closing earnout milestones. Silent-Aire specializes in the design, engineering and manufacturing of mission critical custom air handlers and modular data centers for hyperscale cloud and colocation providers. Silent-Aire s portfolio of data center solutions allow for rapid deployment of critical infrastructure in flexible configurations, with a focus on quality, scalability, and speed-to-market. Silent-Aire s revenue for fiscal year 2021 (May)

Michael isaacRyan edelmanGeorge oliverAntonella franzenDan leckeltChaz bickersMaire coPower solutionsJohnson controlsJohnson controls internationalHyperscale data center companyJohnson controls incData center platformHyperscale data centersLindsey leckelt silent aireStatement regarding forward looking

Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas

Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesFrance generalEva schaefer jansenFrank nestleArnaud delepineSuzanne grecoFelix lauscherFara berkowitzSally bainUlrik nielsenGlobal head of researchEnterprise associatesMyeloma investment fundMission biocapitalMyeloma research foundation